Clinical Trials Browser

Phase 3 × Head and Neck Neoplasms × Educational Status × Clear all

NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Phase 3 Completed

79 enrolled 8 charts

Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis